0
0
April 15, 2026
NEW DELHI — Despite India’s Universal Immunization Programme (UIP) being one of the world’s most expansive public health initiatives, new financial data obtained through Right to Information (RTI) queries reveals a concerning trend: a significant portion of the funds allocated for child vaccinations remains unspent. While the government continues to report high coverage rates, the gap between approved budgets and actual expenditure raises critical questions about administrative bottlenecks, cold-chain logistics, and the consistency of outreach in the country’s most vulnerable districts.
The Numbers Behind the Needle
India’s vaccination machinery is a titan of public health, tasked with reaching approximately 2.67 crore newborns and 2.9 crore pregnant women annually. However, the financial monitoring reports submitted by States and Union Territories paint a picture of underutilization.
According to the RTI-linked data, for the fiscal year 2023-24, the program was allocated ₹3,232 crore, yet expenditure stood at approximately ₹2,250 crore—leaving nearly 30% of the budget untouched. This trend persisted into 2024-25, where roughly ₹1,971 crore was spent against an allocation of ₹3,186 crore.
Current figures for 2025-26 show an increased approved amount of ₹3,434 crore, but as of December, only ₹1,060 crore had been utilized. While these latest figures are provisional, the year-on-year pattern suggests that the challenge is not a lack of political will or funding, but rather the “last mile” execution of the budget.
Why Unspent Funds Matter for Public Health
To the average parent, budget sheets may seem a world away from the local clinic. However, immunization experts argue that financial “underspending” directly impacts the quality of care.
“Immunization is not just about the cost of the vial,” says Dr. Aranya Sen, a public health policy researcher not involved in the RTI report. “It’s about the ‘delivery cost’—the fuel for mobile vans reaching remote villages, the electricity for refrigerators (cold-chain), the training of frontline workers, and the community mobilization needed to fight vaccine hesitancy.”
When funds stagnate at the state or district level, it can lead to:
-
Delayed Outreach: Local “catch-up” campaigns for children who missed doses may be postponed.
-
Logistical Fragility: Maintenance of the cold chain, essential for vaccine potency, requires consistent funding.
-
Data Gaps: The RTI response also highlighted a lack of gender-specific vaccination data, suggesting that fragmented record-keeping may be a byproduct of administrative underfunding.
Success Amidst the Stagnation
It is important to note that India’s immunization story remains one of significant triumph. The Ministry of Health and Family Welfare reported a full immunization coverage of 93.5% for FY 2023-24. Furthermore, the World Health Organization (WHO) recently lauded India for a 43% reduction in “zero-dose” children—those who have not received a single vaccine—dropping from 1.6 million to 0.9 million in 2024.
The National Health Mission (NHM) maintains that the system is reaching between 2.3 crore and 2.5 crore children annually. However, data from the National Family Health Survey (NFHS-5) offers a more sobering perspective, suggesting that only 76.5% of children aged 12-23 months had received all basic vaccinations. This discrepancy between administrative data and survey data underscores the need for every budgeted rupee to be tracked and utilized effectively.
Expert Perspectives: The District-Level Divide
Peer-reviewed analyses of India’s immunization finances indicate that costs are not uniform. A study published in the Indian Journal of Medical Research emphasizes that achieving near-universal coverage requires accounting for district-level variations.
“Strategic planning requires credible, real-time information about where the money is getting stuck,” the study notes. If a district in rural Bihar faces higher delivery costs than one in urban Kerala, a ‘one-size-fits-all’ budget that isn’t fully spent can mask localized crises of access.
The RTI report also pointed toward “fragmented record-keeping.” When gender-wise figures were requested, the query was redirected to another division. For public health advocates, this lack of integrated data makes it difficult to ensure that girls and boys are receiving equitable access to life-saving shots.
Potential Limitations of the Data
While the unspent figures are striking, healthcare analysts urge a balanced interpretation:
-
Provisional Reporting: The 2025-26 figures are current only up to December; spending often surges in the final quarter of the fiscal year.
-
Procurement Cycles: Large-scale vaccine purchases may be subject to global supply chain timings, leading to reporting lags.
-
Efficiency vs. Underspending: In some cases, lower spending could theoretically result from lower procurement costs or improved operational efficiency, though this is rarely the case across all states simultaneously.
What This Means for Families
For the general public, the primary takeaway is a call for vigilance rather than alarm. The vaccines are available, and the program is functioning at a massive scale. However, the administrative gaps suggest that the “safety net” may be thinner in some areas due to budget bottlenecks.
“Parents should continue to follow the National Immunization Schedule rigorously,” says Dr. Sen. “While the government works on smoothing out the financial plumbing, the priority for every family is to ensure their child doesn’t become a statistic in the ‘missed dose’ column.”
As India strives toward its goal of 100% immunization, the focus is shifting from “how much we spend” to “how well we spend.” Ensuring that the ₹3,434 crore allocated for 2025-26 actually reaches the frontline health worker is the next great challenge for the nation’s health.
Reference Section
Primary Sources & Citations:
- https://health.economictimes.indiatimes.com/news/industry/big-share-of-funds-for-kids-jabs-not-spent-rti-data/130249288?utm_source=latest_news&utm_medium=homepage
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
